Genetic Predisposition Testing Program for Pancreatic Neuroendocrine Neoplasms

(PanNEN Trial)

Recruiting in Palo Alto (17 mi)

+2 other locations

Overseen by Emily Bergsland, MD

Age: 18+

Sex: Any

Travel: May Be Covered

Time Reimbursement: Varies

Trial Phase: Academic

Recruiting

Sponsor: University of California, San Francisco

No Placebo Group

Trial Summary

What is the purpose of this trial?

This is a prospective observational multi-center pilot study of germline testing for participants receiving care at University of California participating locations with a new or existing diagnosis of Pancreatic Neuroendocrine Neoplasms (PanNEN). This protocol is an extension of existing Genetic Testing Station efforts at University of California, San Francisco (UCSF)

Eligibility Criteria

Inclusion Criteria

My biopsy was taken from a cancer site.

I am willing and able to follow the study's requirements.

I have a pancreatic neuroendocrine tumor and am over 18.

Treatment Details

Interventions

• Hereditary Cancer Panel (Genetic Testing)

Participant Groups

Group I: Participants with Pancreatic Neuroendocrine Neoplasms Experimental Treatment 1 Intervention

Find a Clinic Near You

Research Locations Nearby Select from list below to view details:

Univeristy of California, San Diego San Diego, CA

University of California, San Francisco San Francisco, CA

University of California, Los Angeles Los Angeles, CA

Who Is Running the Clinical Trial?

University of California, San Francisco Lead Sponsor

Univeristy of California Pancreatic Cancer Consortium (UCPCC) Collaborator

University of California Pancreatic Cancer Consortium (UCPCC) Collaborator

References